Tu YP - Search Results

1

Exposure-response relationships of mirvetuximab soravtansine in patients with folate receptor-α-positive ovarian cancer: Justification of therapeutic dose regimen.

Tu YP, Lagraauw HM, Method M, Wang Y, Hanze E, Li L, Parrott T, Sloss CM, Westin EH. Tu YP, et al. Br J Clin Pharmacol. 2025 Jan;91(1):220-231. doi: 10.1111/bcp.16250. Epub 2024 Sep 22. Br J Clin Pharmacol. 2025. PMID: 39307840 Clinical Trial.

2

Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor-α positive ovarian cancer: The antibody-drug conjugate, payload and metabolite.

Tu YP, Hanze E, Zhu F, Lagraauw HM, Sloss CM, Method M, Esteves B, Westin EH, Berkenblit A. Tu YP, et al. Br J Clin Pharmacol. 2024 Feb;90(2):568-581. doi: 10.1111/bcp.15937. Epub 2023 Nov 13. Br J Clin Pharmacol. 2024. PMID: 37872122

3

Assessment of mirvetuximab soravtansine immunogenicity in patients with folate receptor alpha-positive ovarian cancer.

Zhu F, Tu YP, Sloss C, Wang Y. Zhu F, et al. Among authors: tu yp. Bioanalysis. 2024;16(21-22):1101-1113. doi: 10.1080/17576180.2024.2407228. Epub 2024 Oct 8. Bioanalysis. 2024. PMID: 39378056 Free PMC article.

4

COVID-19 Antigen Results Correlate with the Quantity of Replication-Competent SARS-CoV-2 in a Cross-Sectional Study of Ambulatory Adults during the Delta Wave.

Tu YP, Green C, Hao L, Greninger AL, Morton JF, Sights HA, Gale M Jr, Drain PK. Tu YP, et al. Microbiol Spectr. 2023 Jun 15;11(3):e0006423. doi: 10.1128/spectrum.00064-23. Epub 2023 Apr 25. Microbiol Spectr. 2023. PMID: 37097146 Free PMC article.

5

Path Planning and Motion Control of Indoor Mobile Robot under Exploration-Based SLAM (e-SLAM).

Roy R, Tu YP, Sheu LJ, Chieng WH, Tang LC, Ismail H. Roy R, et al. Among authors: tu yp. Sensors (Basel). 2023 Mar 30;23(7):3606. doi: 10.3390/s23073606. Sensors (Basel). 2023. PMID: 37050664 Free PMC article.

6

A Novel Low Complexity Two-Stage Tone Reservation Scheme for PAPR Reduction in OFDM Systems.

Tu YP, Chang CC. Tu YP, et al. Sensors (Basel). 2023 Jan 13;23(2):950. doi: 10.3390/s23020950. Sensors (Basel). 2023. PMID: 36679746 Free PMC article.

7

Correction to "SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial".

Tandon M, Wu W, Moore K, Winchester S, Tu YP, Miller C, Kodgule R, Pendse A, Rangwala S, Joshi S. Tandon M, et al. Among authors: tu yp. Lancet Reg Health Southeast Asia. 2022 Dec;7:100110. doi: 10.1016/j.lansea.2022.100110. Epub 2022 Nov 6. Lancet Reg Health Southeast Asia. 2022. PMID: 36373109 Free PMC article.

8

Effect of environmental regulation policy synergy on carbon emissions in China under consideration of the mediating role of industrial structure.

Lu W, Wu H, Yang S, Tu YP. Lu W, et al. Among authors: tu yp. J Environ Manage. 2022 Nov 15;322:116053. doi: 10.1016/j.jenvman.2022.116053. Epub 2022 Aug 28. J Environ Manage. 2022. PMID: 36044823

9

SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial.

Tandon M, Wu W, Moore K, Winchester S, Tu YP, Miller C, Kodgule R, Pendse A, Rangwala S, Joshi S; Study Group. Tandon M, et al. Among authors: tu yp. Lancet Reg Health Southeast Asia. 2022 Aug;3:100036. doi: 10.1016/j.lansea.2022.100036. Epub 2022 Jun 29. Lancet Reg Health Southeast Asia. 2022. PMID: 35784831 Free PMC article.

10

Houston We Have a Problem: Ground Zero for the US Coronavirus Outbreak.

Tu YP. Tu YP. Narrat Inq Bioeth. 2021;11(1):E1-E5. doi: 10.1353/nib.2021.0014. Narrat Inq Bioeth. 2021. PMID: 34334445 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters